Advertisement
News

EMA to decide on Johnson and Johnson vaccine next week

Apr 14, 2021 17:33 By Shannonside News
EMA to decide on Johnson and Johnson vaccine next week
Share this article

The EMA says it is investigating the six reported cases along with US regulators

The European Medicines Agency insists the benefits of the Johnson and Johnson vaccine outweigh the risks of side effects.

Its rollout has been delayed in Europe as the company investigates rare blood clots in people who have received the vaccine in the US.

The EMA says it is investigating the six reported cases along with US regulators.

Advertisement

Next week the EMA will decide whether any regulatory action needs to be taken on the single-shot vaccine.

Share this article
Advertisement
Advertisement

Shannonside Newsletter

Sign up now to keep up to date with the latest news.

Processing your request...

You are subscribed now! please check your email to confirm your subscription.

Copyright © 2024 Shannonside FM. Developed by Square1 and Powered by PublisherPlus